thai09: der mueslifxxx poster 28.08.12 07:25
william09 findet das witzig.. scheisse wenn man kein englisch kann... loool ...geh in deinen muesli thread . was laufen eigentlich fuer xxxxx in den boersenthreads herum....
Key Developments: BioSante Pharmaceuticals Inc (BPAX.O)Related Topics: StocksStock ScreenerMarket DataHealthcareBiotechnology / Medical ResearchOverviewNewsKey DevelopmentsPeopleChartsFinancialsOptionsAnalystsResearchPulseBPAX.O on Consolidated Issue listed on NASDAQ Global Market
1.55USD 27 Aug 2012 Price Change (% chg)
$0.07 (+4.73%) Prev Close $1.48 Open $1.55 Day's High $1.60 Day's Low $1.41 Volume 1,760,206 Avg. Vol 540,885 52-wk High $17.58 52-wk Low $1.21 Search Stocks Latest Key DevelopmentsBioSante Pharmaceuticals Inc Closes $3,475,000 Registered Direct Offering Monday, 20 Aug 2012 05:00pm EDT BioSante Pharmaceuticals Inc announced the closing of the sale of 2,359,932 shares of its common stock and warrants to purchase up to 1,179,966 additional shares of its common stock in a registered direct offering, resulting in gross cash proceeds to BioSante of $3,475,000. BioSante received net proceeds of approximately $3.3 million after deducting placement agent fees and other offering expenses. Each unit, consisting of one share of common stock and a warrant to purchase 0.5 of a share of common stock,####### was sold to one institutional investor for a purchase price of $1.4725, which was a premium to the closing price on the day before pricing. ####### The warrants are exercisable immediately at an exercise price of $1.50 per share and will expire on August 17, 2017. Proceeds from the transaction will be used for general corporate purposes, including increasing the Company`s cash reserve for payment of its 3.125% convertible senior notes due May 1, 2013 and to fund its LibiGel clinical activities. Rodman & Renshaw, LLC acted as the exclusive placement agent for the transaction. From time to time, Roth Capital has served as a financial advisor to BioSante. Full Article - - - - - (repeated) BioSante Pharmaceuticals Inc To Raise $3,475,000 In Registered Direct Offering Friday, 17 Aug 2012 09:30am EDT BioSante Pharmaceuticals Inc announced that it has received a commitment from an institutional investor to purchase $3,475,000 of securities in a registered direct offering. BioSante expects to receive net proceeds of approximately $3.3 million after deducting placement agent fees and other offering expenses. BioSante has entered into a securities purchase agreement with this investor pursuant to which BioSante has agreed to sell 2,359,932 shares of its common stock and warrants to purchase up to 1,179,966 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.5 of a share of common stock, will be sold for a purchase price of $1.4725, a premium to the closing price on the day before pricing. The warrants to purchase additional shares will be exercisable at an exercise price of $1.50 per share beginning immediately and will expire five years from their date of issuance. All of the securities were offered pursuant to an effective shelf registration statement. Proceeds from the transaction will be used for general corporate purposes, including increasing its cash reserve for payment of its 3.125% convertible senior notes due May 1, 2013 and to fund its LibiGel clinical activities. The offering is expected to be consummated by August 21, 2012. Rodman & Renshaw, LLC is acting as the exclusive placement agent for the transaction.
http://www.reuters.com/finance/stocks/BPAX.O/key-developments
Es liegen folgende Meldungen zu diesem Posting vor:
Meldung eines Regelverstoßes: Melder: william9 Zeitpunkt: 29.08.12 00:30 Grund: ist das Stil von ARIVA-Börse oder nur der Stil eines sehr, sehr naiven Pushers?
ein beweis , sing is coming ... nb das ist ein vergleich und hat nix mit ner threadfremden aktie zu tun... nachdenken ! wo ich hin will |